Apparatus and Methods for Monitoring and Modifying Anticoagulation Therapy of Remotely Located Patients
First Claim
1. A method of monitoring anticoagulation therapy of a patient, wherein the anticoagulation therapy includes a patient-administered medication regimen selected from the group consisting of warfarin and vitamin K antagonists, heparin and glucosaminoglycans, and direct thrombin inhibitors, and a patient-administered regimen for a coagulation test that monitors efficacy of the medication regimen, wherein the coagulation test is selected from the group consisting of prothrombin time (PT) test, partial thromboplastin time (PTT) test, activated clotting time (ACT) test, heparin assays, ecarin clotting time (ECT) test, and thrombin clotting time test, wherein the apparatus is configured to receive and analyze information regarding patient compliance with the patient-administered medication and coagulation test regimens, and wherein the apparatus is configured to modify the patient-administered medication and coagulation test regimens, the method comprising the following steps performed by a portable apparatus:
- receiving data from a patient, wherein the patient data includes at least one of physiological data, pathophysiological data, biological data, psychological data, neuropsychological data, and behavioral data;
assessing severity of the received patient data;
prompting the patient to perform a patient-administered coagulation test if the received patient data are assessed to be above a threshold severity level;
receiving coagulation test results from the patient-administered test; and
communicating the received coagulation test results from the patient-administered test to a healthcare provider via a communications network.
5 Assignments
0 Petitions
Accused Products
Abstract
A patient apparatus is configured to receive and analyze information regarding patient compliance with anticoagulation medication and self-test coagulation regimens related to anticoagulation therapy. In addition, a patient apparatus is configured to receive data from a patient, including physiological data, pathophysiological data, biological data, psychological data, neuropsychological data, and/or behavioral data. Utilizing the received patient data, a patient apparatus can modify a warfarin regimen using an algorithm contained within the apparatus. The apparatus can communicate the modified warfarin regimen to the patient and to third parties, such as remotely located healthcare providers. In addition, the apparatus can prompt a patient when to perform a self-test and can prompt a patient to seek immediate medical attention, or to directly contact medical help, when so warranted.
-
Citations
43 Claims
-
1. A method of monitoring anticoagulation therapy of a patient, wherein the anticoagulation therapy includes a patient-administered medication regimen selected from the group consisting of warfarin and vitamin K antagonists, heparin and glucosaminoglycans, and direct thrombin inhibitors, and a patient-administered regimen for a coagulation test that monitors efficacy of the medication regimen, wherein the coagulation test is selected from the group consisting of prothrombin time (PT) test, partial thromboplastin time (PTT) test, activated clotting time (ACT) test, heparin assays, ecarin clotting time (ECT) test, and thrombin clotting time test, wherein the apparatus is configured to receive and analyze information regarding patient compliance with the patient-administered medication and coagulation test regimens, and wherein the apparatus is configured to modify the patient-administered medication and coagulation test regimens, the method comprising the following steps performed by a portable apparatus:
-
receiving data from a patient, wherein the patient data includes at least one of physiological data, pathophysiological data, biological data, psychological data, neuropsychological data, and behavioral data; assessing severity of the received patient data; prompting the patient to perform a patient-administered coagulation test if the received patient data are assessed to be above a threshold severity level; receiving coagulation test results from the patient-administered test; and communicating the received coagulation test results from the patient-administered test to a healthcare provider via a communications network. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. An apparatus that monitors anticoagulation therapy of a patient, wherein the anticoagulation therapy includes a patient-administered medication regimen selected from the group consisting of warfarin and vitamin K antagonists, heparin and glucosaminoglycans, and direct thrombin inhibitors, and a patient-administered regimen for a coagulation test that monitors efficacy of the medication regimen, wherein the coagulation test is selected from the group consisting of prothrombin time (PT) test, partial thromboplastin time (PTT) test, activated clotting time (ACT) test, heparin assays, ecarin clotting time (ECT) test, and thrombin clotting time test, comprising:
-
a processor; a user interface in communication with the processor; computer code executable by the processor that receives and stores data from a patient, wherein the patient data includes at least one of physiological data, pathophysiological data, biological data, psychological data, neuropsychological data, and behavioral data; computer code executable by the processor that assesses severity of the received patient data; computer code executable by the processor that prompts a patient via the user interface to perform a patient-administered coagulation test if the received patient data are assessed to be above a threshold severity level; computer code executable by the processor that receives and stores coagulation test results from the patient-administered coagulation test; computer code executable by the processor that communicates the received coagulation test results from the patient-administered coagulation test to a healthcare provider via a communications network. - View Dependent Claims (11, 12, 13, 14, 15, 16, 17, 18)
-
-
19. A system that monitors anticoagulation therapy of a patient, wherein the anticoagulation therapy includes a patient-administered medication regimen selected from the group consisting of warfarin and vitamin K antagonists, heparin and glucosaminoglycans, and direct thrombin inhibitors, and a patient-administered regimen for a coagulation test that monitors efficacy of the medication regimen, wherein the coagulation test is selected from the group consisting of prothrombin time (PT) test, partial thromboplastin time (PTT) test, activated clotting time (ACT) test, heparin assays, ecarin clotting time (ECT) test, and thrombin clotting time test, wherein the system comprises:
-
a patient apparatus, comprising; a processor; a user interface in communication with the processor; computer code executable by the processor that receives and stores data from a patient, wherein the patient data includes at least one of physiological data, pathophysiological data, biological data, psychological data, neuropsychological data, and behavioral data; computer code executable by the processor that assesses severity of the received patient data; computer code executable by the processor that prompts the patient via the user interface to perform a patient-administered coagulation test if the received patient data are assessed to be above a threshold severity level; computer code executable by the processor that receives and stores coagulation test results from the patient-administered coagulation test; and computer code executable by the processor that communicates the received coagulation test results from the patient-administered coagulation test to a healthcare provider via a communications network; and a remotely located data processing system configured to communicate with and receive data from the patient apparatus, the remotely located data processing system comprising; computer code that obtains patient data from the patient apparatus; computer code that analyzes the obtained patient data from to identify medical conditions of a patient; computer code that displays identified patient medical conditions for a patient in selectable, prioritized order according to medical severity via a remotely located client in communication with the central data processing system; and computer code that displays treatment options for treating a selected medical condition for a patient. - View Dependent Claims (20, 21, 22, 23, 24, 25, 26, 27, 28)
-
-
29. A method of monitoring disease therapy of a patient, wherein the disease is selected from the group consisting of asthma, cancer chemotherapy, depression, high blood pressure, seizure disorders, and thrombosis, wherein the disease therapy includes a patient-administered medication regimen and a patient-administered regimen for a test that monitors efficacy of the medication regimen, wherein the apparatus is configured to receive and analyze information regarding patient compliance with the patient-administered medication and test regimens, and wherein the apparatus is configured to modify the patient-administered medication and test regimens, the method comprising the following steps performed by the apparatus:
-
receiving data from a patient, wherein the patient data includes at least one of physiological data, pathophysiological data, biological data, psychological data, neuropsychological data, and behavioral data; assessing severity of the received patient data; prompting the patient to perform a patient-administered test if the received patient data are assessed to be above a threshold severity level; receiving test results from the patient-administered test; and communicating the received test results from the patient-administered test to a healthcare provider via a communications network. - View Dependent Claims (30, 31, 32, 33, 34, 35, 36)
-
-
37. An apparatus that monitors disease therapy of a patient, wherein the disease is selected from the group consisting of asthma, cancer chemotherapy, depression, high blood pressure, seizure disorders, and thrombosis, wherein the disease therapy includes a patient-administered medication regimen and a patient-administered regimen for a test that monitors efficacy of the medication regimen, the apparatus comprising:
-
a processor; a user interface in communication with the processor; computer code executable by the processor that receives and stores data from a patient, wherein the patient data includes at least one of physiological data, pathophysiological data, biological data, psychological data, neuropsychological data, and behavioral data; computer code executable by the processor that assesses severity of the received patient data; computer code executable by the processor that prompts the patient via the user interface to perform a patient-administered test if the received patient data are assessed to be above a threshold severity level; computer code executable by the processor that receives and stores test results from the patient-administered test; and computer code executable by the processor that communicates the received test results from the patient-administered test to a healthcare provider via a communications network. - View Dependent Claims (38, 39, 40, 41, 42, 43)
-
Specification